Journal of Pharmacopuncture (대한약침학회지)

KOREAN PHARMACOPUNCTURE INSTITUTE (대한약침학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of herb drug medicine Treatment for Functional Dyspepsia: Controlled Trial

기능성 소화불량증 환자에 대한 한약복합제형간의 비교 임상시험: 대조군 연구

  • Lee, Jae-Jin (Dept. of Acupuncture & Moxibustation, College of Oriental Medicine, Daejeon University) ;
  • Son, Mi-Won (Dong-A Pharmaceutical Co.) ;
  • Hong, Kwon-Eui (Dept. of Acupuncture & Moxibustation, College of Oriental Medicine, Daejeon University)
  • 이재진 (대전대학교 한의과대학 침구학 교실) ;
  • 손미원 (동아제약) ;
  • 홍권의 (대전대학교 한의과대학 침구학 교실)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Functional dyspepsia is a prevalent disease. It impedes subjective quality of life. The purpose of this research is to examine the equivalent effect of herb drug medicine treatment(H-D)and Over the Counter(OTC) for functional dyspepsia. Method : In this controlled study, we compared herb drug medicine(H-D) with Over the Counter(OTC) of functional dyspepsia. 30 volunteers who satisfied the requirements were enrolled in study. Severity of dyspepsia was measured by Nepean Dyspepsia Index(NDI-K) before and after treatments. Result : The results are summarized as follows. 1. In Herb drug medicine and Over the Counter groups, total key symptoms score of after treatment were significantly decreased and improve rate of key symptoms was higher than before treatment, but there were no statistical significance between two groups. 2. In Herb drug medicine and Over the Counter groups, each symptoms score of after treatment were significantly decreased and improve rate of key symptoms was higher than before treatment, but there were no statistical significance between two groups. 3. In Herb drug medicine and Over the Counter groups, quality of life score of after treatment were significantly decreased and improve rate of key symptoms was higher than before treatment, but there were no statistical significance between two groups. Conclusion : Herb drug medicine treatment(H-D) is effective to improve the symptoms and quality of life in patients with functional dyspepsia.

Keywords

References

  1. Choi MG. Definition and Epidemilogy of Functional Dyspepsia. The Korean Society of Gastrointestinal Motility. 2000;6:235-40
  2. Lee JH, Kim HY, Rho SH, Yoon DH, Kim KH, Choi JH. Which Patients do examinate Endoscopy Test on Functional Dyspepsia in Korea. The Korean Society of Gastrointestinal Motility. 2001;22:1-7
  3. Park YT. Approch Definition and Diagnosis of Dyspepsia, Seoul, Jin publishing. 2006:13-29
  4. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45(Suppl II):37-42 https://doi.org/10.1136/gut.45.2008.ii37
  5. Huh C, Yang CH, Jang JG, Lee DH, Lee GL, Seol SY, Lee YJ, Han YS, Rim KS, Rhee PL, Shin WC, Lee KJ, Chung MK, Na YH. Functional Dyspepsia and Subgroups in Korea and Short Term Outcome of Therapeutic Trial of Cisapride ; Multicenter Study. The Korean Society of Gastrointestinal Motility. 1998;4(1):1-12
  6. Lee SY, Choi CH, Lee HY, Do MY, Lee SH, Han SP, Huh C, Kin HJ, Kim JY, Kim JG, Jang SK, Park SM. Original Articles : The Frequency of Functional Dyspepsia Subtypes and its Related Factors for Health Check up Subjects. The Korean Society of Gastrointestinal Motility. 2007;13:31-7
  7. 전국한의과대학 비계내과학교수. 비계내과학. Seoul: Dong-Woo Publishing co. 2000:51-62, 65-74, 83-8, 154-9
  8. 지상원, 박효진, 이풍렬, 이오영, 김동기. Effects of Mosapride on Upper Gastrointestinal Symptoms and Gastric Emptying in Patients with Functional Dyspepsia. The Korean Society of Gastrointestinal Motility. 2004;10(1):27-34
  9. 한요셉, 장영운, 장린. A Randomized Study to Compare Domperidone Maleate with Itopride Hydrochloride in Dysmotility-type Functional Dyspepsia. The Korean Society of Gastrointestinal Motility. 2003;41:284-9
  10. 김종윤, 이진용, 윤상협. 기능성 소화불량증 환아의 위전도에 대한 내소화중탕의 효과. 대한한방소아과학회지. 2002;16(2):199-213
  11. 윤상협, 류봉하, 류기원, 김진성. 기능성 소화불량증 환자에 대한 반하사심탕 엑기스제의 임상효과. 대한한방내과학회지. 2003;24(2):329-36
  12. 오중한, 김봉석, 임희용, 김동우, 최빈혜, 허진일, 김대준, 조종관, 변준석. 이진탕 가미방 투여 후 호전된 기능성 소화불량 환자 3례에 대한 증례보고. 대한한방내과학회지. 2005;26(3):641-51
  13. 원종만, 윤상협, 김진성, 류봉하. 육군자탕이 흰쥐의위 배출능에 미치는 영향. 대한한방내과학회지. 2007;28(2):242-9
  14. 김진석. 내소산의 정상 및 위 유문부 확장 흰쥐의 위운동성에 대한 효능. 서울: 경희대학교 대학원. 2008:1-29
  15. 남효익, 김회영, 손현수, 임성우. 정전가미이진탕이 흰쥐의 위배출능에 미치는 영향. 대한한방내과학회지. 2007;28(2):209-16
  16. Jones RH, Lydeard SE, Hobbs FD. Dyspepsia in England and Scotland. Gut. 1990;31:401-5 https://doi.org/10.1136/gut.31.4.401
  17. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671-80 https://doi.org/10.1016/0016-5085(95)90373-9
  18. 김동진. 불규칙한 식사, 짧은 식사시간이 비궤양성 소화불량증과 연관됨. 가정의학회지. 1999;20(2):176-85
  19. Kim HS, Lee GJ, Kim JH, Ham KB, Cho SW. Functional Gastrointestinal Disorders in Patients Referred to Specialist Gastroenterologists in a Tertiary Hospital. The Korean Society of Gastrointestinal Motility . 2004;10(2):111-7
  20. Lee GJ. Pathophysiology and Treatment of Functional Dyspepsia. The Korean Society of Gastrointestinal Motility 2003;9:85-91
  21. Lee GJ. Guidline of Treatment on Functional Dyspepsia. The Korean Society of Gastrointestinal Motility. 2005;11(3):25-9
  22. Ko KB. Aspect of Spycosociology for functional dyspepsia. The Korean Society of Gastrointestinal Motility. 2000;6:258-66
  23. 전국한의과대학 본초학교수. 본초학. 서울: 영림사. 1998;289-90, 291-2, 334-5, 336-7, 342-3, 344-5, 348-9, 413-4, 612-3
  24. 식품의약품안전청 편집부. 대한약전. 서울: 신일상사. 2008;1202-1203
  25. Bond EF, Heitkemper MM, Bailey SL. Estrogen suppresses gastric motility response to thyrotropin-releasing to hormone and stress in awake rats. Res Nurs Health.1998;21(3):221-8 https://doi.org/10.1002/(SICI)1098-240X(199806)21:3<221::AID-NUR5>3.0.CO;2-J
  26. Heitkemper MM, Bond EF. Gastric motility in rats with varying ovarian hormone status. Res Nurs Health. 1995;17(1):9-19 https://doi.org/10.1177/019394599501700102
  27. 신현규. 한약제제등의 임상시험가이드라인 제정연구(II). 서울: 식품의약품안정청연구결과보고서. 2005:135-44
  28. Park YC, Jo JH, Hong KE, Jung YC, Kang WC, Choi SM. Effect of Acupuncture Treatment for Functional Dyspepsia: A Randomized Controlled Trial. The Journal of Korean Acupuncture and Moxibustion Society . 2007;24(1):1-12
  29. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13(2):225-35 https://doi.org/10.1046/j.1365-2036.1999.00445.x
  30. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999;94(9):2390-7 https://doi.org/10.1111/j.1572-0241.1999.01363.x
  31. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001;15(2):207-16 https://doi.org/10.1046/j.1365-2036.2001.00900.x
  32. Katz S. The science of quality of life. J Chronic Dis. 1987;40:459-63 https://doi.org/10.1016/0021-9681(87)90001-4
  33. Choi MG. Quality of Life in Functional Dyspepsia. The Korean of Gastroenterology. 2002;spr:55-65
  34. Jo YK, Choi MG, Kim SH, Lee YS, Kim SY, Jeong YS, Lee SL, Choi SC, Seol SY. The Effect of Mosapride on Quality of Life in Functional Dyspepsia. The Korean of Gastroenterology. 2004;43(3):160-7